Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Oral Genome Corp. has 1 pending office action within the Chemistry & Materials technology area. This single case is being reviewed by 1 distinct examiner in 1 distinct art unit, which centralizes the company's current patent office interactions. This narrow focus means that the company's immediate intellectual property goals are concentrated in one specific technical group.
COLENA, TRACY CHING-TIAN is the busiest examiner, holding the 1 pending office action. With only 1 distinct examiner involved, the company's immediate prosecution success relies on the feedback from this individual official. There is no opportunity to compare this examiner's behavior against others within the company's current pending portfolio.
Practitioners should recognize that the 1 pending office action represents the entire active footprint of the company at the USPTO. Because this action is handled by 1 distinct art unit, the prosecution strategy must be highly specific to the technical standards of that unit. The outcome of the company's current patenting efforts is entirely in the hands of COLENA, TRACY CHING-TIAN, making examiner-specific research a priority.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLENA, TRACY CHING-TIAN | 1 | 81.8% | +42.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18422976 | SALIVA PAIRED IMAGING TEST APPARATUS AND METHOD | COLENA, TRACY CHING-TIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18422976 | SALIVA PAIRED IMAGING TEST APPARATUS AND METHOD | COLENA, TRACY CHING-TIAN | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18422976 | SALIVA PAIRED IMAGING TEST APPARATUS AND METHOD | COLENA, TRACY CHING-TIAN | 1797 | §103§112 | Non-Final OA | — | Pending | Jan 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOral Genome Corp. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Tracy Ching-Tian Colena has the most, with 1 of Oral Genome Corp.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
